{Reference Type}: Journal Article
{Title}: Mucosa-penetrating liposomes for esophageal local drug delivery.
{Author}: Franzé S;Rama F;Scarpa E;Violatto MB;Peqini K;Gennari CGM;Anderluzzi G;Camastra R;Salmaso A;Moscatiello G;Pellegrino S;Rizzello L;Bigini P;Cilurzo F;
{Journal}: Int J Pharm
{Volume}: 661
{Issue}: 0
{Year}: 2024 Jul 1
{Factor}: 6.51
{DOI}: 10.1016/j.ijpharm.2024.124413
{Abstract}: Local drug delivery to the esophagus is hampered by rapid transit time and poor permeability of the mucosa. If some strategies aimed to improve the residence time have been proposed, non-invasive approaches to increase the drug penetration in the mucosa have not been described so far. Herein, we designed mucosa-penetrating liposomes to favor the penetration and retention of curcumin (CURC) in the esophagus. A novel mucosa penetrating peptide (MPP), SLENKGP, was selected by Phage Display and conjugated to pegylated liposomes at different PEG and MPP's surface densities. Pegylation assured a long residence time of liposomes (at least 30 min) in the esophagus in vivo, but it did not favor the penetration of CURC in the mucosa. MPP-decorated liposomes instead delivered a significant higher amount of CURC in the mucosa compared to naked pegylated liposomes. Confocal microscopy studies showed that naked pegylated liposomes remain confined in the superficial layers of the mucosa whereas MPP-decorated liposomes penetrate the whole epithelium. In vitro, MPP reduced the interaction of PEG with mucin, meanwhile favoring the paracellular penetration of liposomes across epithelial cell multilayers. In conclusion, pegylated liposomes represent a valid approach to target the esophagus and the surface functionalization with MPP enhances their penetration in the mucosa.